{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:44:31Z","timestamp":1794008671455,"version":"4.8.0"},"reference-count":58,"publisher":"American Society of Hematology","issue":"1","license":[{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1,14]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>The G haplotype is a group of co-inherited single nucleotide variants in the F5 gene that reduce venous thromboembolism (VTE) risk. Although 7% of the population is homozygous for the G haplotype (F5-G\/G), the underlying mechanism of VTE protection is poorly understood. Using RNA sequencing data from 4651 blood donors in the INTERVAL study, we detected a rare excision event at the factor V (FV)-short splice sites in 5% of F5-G\/Gs carriers as compared with 2.16% of homozygotes for the F5 reference sequence (F5-ref; P\u00a0=\u00a0.003). Highly elevated (\u223c10-fold) FV-short, a FV isoform that lacks most of the B-domain, has been linked with increased tissue factor inhibitor \u03b1 (TFPI\u03b1) levels in rare hemorrhagic diathesis, including East Texas bleeding disorder. To ascertain whether the enhanced FV-short splicing seen in F5-G\/G INTERVAL participants translated to increased plasma FV-short levels, we analyzed plasma samples from 7 F5-G\/G and 13 F5-ref individuals in a recall-by-genotype study. A \u223c2.2-fold higher amount of FV-short was found in a plasma pool from F5-G\/G participants when compared with the pool of F5-refs (P\u00a0=\u00a0.029), but there was no difference in the total FV levels. Although no significant difference in TFPI levels were found, F5-G\/Gs showed a \u223c1.4-fold TFPI-dependent increase in lag time to thrombin generation than F5-refs (P\u00a0=\u00a0.0085). Finally, in an analysis of 117\u2009699 UK Biobank participants, we discovered that, although being protective against VTE, the G haplotype also confers an increase in bleeding episodes (P\u00a0=\u00a0.011). Our study provides evidence that the effect of the common G haplotype is mediated by the FV-short\/TFPI pathway.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024014020","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T21:06:19Z","timestamp":1728075979000},"page":"132-142","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["The common VTE-protective G haplotype of <i>F5<\/i> increases factor V-short, TFPI function, and risk of bleeding"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4503-0265","authenticated-orcid":false,"given":"Matthew C.","family":"Sims","sequence":"first","affiliation":[{"name":"1Department of Haematology, University of Cambridge, Cambridge, United Kingdom"},{"name":"2National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom"},{"name":"3Department of Haematology, Sheffield Teaching Hospitals National Health Service Foundation Trust, Sheffield, United Kingdom"},{"name":"4Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Gierula","sequence":"additional","affiliation":[{"name":"5Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C.","family":"Stephens","sequence":"additional","affiliation":[{"name":"1Department of Haematology, University of Cambridge, Cambridge, United Kingdom"},{"name":"6National Institute for Health and Care Research BioResource, Cambridge University Hospitals, Cambridge Biomedical Campus, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4222-7484","authenticated-orcid":false,"given":"Alex","family":"Tokolyi","sequence":"additional","affiliation":[{"name":"7Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4352-1151","authenticated-orcid":false,"given":"Luca","family":"Stefanucci","sequence":"additional","affiliation":[{"name":"1Department of Haematology, University of Cambridge, Cambridge, United Kingdom"},{"name":"2National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom"},{"name":"8British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9104-1972","authenticated-orcid":false,"given":"Elodie","family":"Persyn","sequence":"additional","affiliation":[{"name":"9Department of Public Health and Primary Care, British Heart Foundation Cardiovascular Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom"},{"name":"10Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, United Kingdom"},{"name":"11Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luanluan","family":"Sun","sequence":"additional","affiliation":[{"name":"9Department of Public Health and Primary Care, British Heart Foundation Cardiovascular Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8716-3261","authenticated-orcid":false,"given":"Janine H.","family":"Collins","sequence":"additional","affiliation":[{"name":"1Department of Haematology, University of Cambridge, Cambridge, United Kingdom"},{"name":"2National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom"},{"name":"12Department of Haematology, Barts Health National Health Service Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma E.","family":"Davenport","sequence":"additional","affiliation":[{"name":"7Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Di Angelantonio","sequence":"additional","affiliation":[{"name":"8British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom"},{"name":"9Department of Public Health and Primary Care, British Heart Foundation Cardiovascular Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom"},{"name":"10Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, United Kingdom"},{"name":"13National Institute for Health and Care Research Blood and Transplant Research Unit in Donor Health and Behaviour, Cambridge, United Kingdom"},{"name":"14Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, United Kingdom"},{"name":"15Health Data Science Centre, Human Technopole, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0366-1579","authenticated-orcid":false,"given":"Kate","family":"Downes","sequence":"additional","affiliation":[{"name":"1Department of Haematology, University of Cambridge, Cambridge, United Kingdom"},{"name":"2National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom"},{"name":"16Cambridge Genomics Laboratory, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Inouye","sequence":"additional","affiliation":[{"name":"8British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom"},{"name":"9Department of Public Health and Primary Care, British Heart Foundation Cardiovascular Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom"},{"name":"10Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, United Kingdom"},{"name":"11Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom"},{"name":"17Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8230-0116","authenticated-orcid":false,"given":"Dirk S.","family":"Paul","sequence":"additional","affiliation":[{"name":"9Department of Public Health and Primary Care, British Heart Foundation Cardiovascular Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom"},{"name":"10Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, United Kingdom"},{"name":"18Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will","family":"Thomas","sequence":"additional","affiliation":[{"name":"19Department of Haematology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9163-7127","authenticated-orcid":false,"given":"Alexander","family":"Tolios","sequence":"additional","affiliation":[{"name":"20Department of Transfusion Medicine and Cell Therapy, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7744-1790","authenticated-orcid":false,"given":"Willem H.","family":"Ouwehand","sequence":"additional","affiliation":[{"name":"1Department of Haematology, University of Cambridge, Cambridge, United Kingdom"},{"name":"2National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom"},{"name":"19Department of Haematology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom"},{"name":"21Department of Haematology, University College London Hospitals National Health Service Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1132-1059","authenticated-orcid":false,"given":"Nicholas S.","family":"Gleadall","sequence":"additional","affiliation":[{"name":"1Department of Haematology, University of Cambridge, Cambridge, United Kingdom"},{"name":"2National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6723-7841","authenticated-orcid":false,"given":"James T. B.","family":"Crawley","sequence":"additional","affiliation":[{"name":"5Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6915-9015","authenticated-orcid":false,"given":"Adam S.","family":"Butterworth","sequence":"additional","affiliation":[{"name":"8British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom"},{"name":"9Department of Public Health and Primary Care, British Heart Foundation Cardiovascular Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8074-6299","authenticated-orcid":false,"given":"Mattia","family":"Frontini","sequence":"additional","affiliation":[{"name":"1Department of Haematology, University of Cambridge, Cambridge, United Kingdom"},{"name":"2National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom"},{"name":"8British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom"},{"name":"22Department of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5313-6508","authenticated-orcid":false,"given":"Josefin","family":"Ahnstr\u00f6m","sequence":"additional","affiliation":[{"name":"5Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"issue":"5","key":"2025011415312003600_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/07853890.2011.576698","article-title":"Inherited disorders of blood coagulation","volume":"44","author":"Lippi","year":"2012","journal-title":"Ann Med"},{"issue":"4","key":"2025011415312003600_bib2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","article-title":"Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders","volume":"10","author":"Peyvandi","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"2025011415312003600_bib3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.7326\/0003-4819-138-2-200301210-00014","article-title":"Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system","volume":"138","author":"Crowther","year":"2003","journal-title":"Ann Intern Med"},{"issue":"1","key":"2025011415312003600_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/jth.14343","article-title":"High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor","volume":"17","author":"Rietveld","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"2025011415312003600_bib5","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1101\/gr.213611.116","article-title":"Evaluation of GRCh38 and de novo haploid genome assemblies demonstrates the enduring quality of the reference assembly","volume":"27","author":"Schneider","year":"2017","journal-title":"Genome Res"},{"issue":"4","key":"2025011415312003600_bib6","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jtha.2023.01.033","article-title":"Natural anticoagulant discovery, the gift that keeps on giving: finding FV-Short","volume":"21","author":"Dahlback","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"issue":"7","key":"2025011415312003600_bib7","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1016\/S0021-9258(18)61503-0","article-title":"Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism","volume":"262","author":"Krishnaswamy","year":"1987","journal-title":"J\u00a0Biol Chem"},{"issue":"44","key":"2025011415312003600_bib8","doi-asserted-by":"crossref","first-page":"17838","DOI":"10.1073\/pnas.1310444110","article-title":"Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation","volume":"110","author":"Wood","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2025011415312003600_bib9","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1111\/jth.15025","article-title":"Anticoagulant protein S-New insights on interactions and functions","volume":"18","author":"Gierula","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6475","key":"2025011415312003600_bib10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"issue":"2","key":"2025011415312003600_bib11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0038-1650556","article-title":"Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII: influence of the factor VR506Q mutation","volume":"76","author":"Varadi","year":"1996","journal-title":"Thromb Haemost"},{"issue":"11","key":"2025011415312003600_bib12","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/s41588-019-0519-3","article-title":"Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease","volume":"51","author":"Klarin","year":"2019","journal-title":"Nat Genet"},{"issue":"7993","key":"2025011415312003600_bib13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","article-title":"A\u00a0genomic mutational constraint map using variation in 76,156 human genomes","volume":"625","author":"Chen","year":"2024","journal-title":"Nature"},{"issue":"1","key":"2025011415312003600_bib14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jtha.2022.10.014","article-title":"Factor V Leiden-independent activated protein C resistance: communication from the Plasma Coagulation Inhibitors Subcommittee of the International Society on Thrombosis and Haemostasis Scientific and Standardisation Committee","volume":"21","author":"Moore","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"2025011415312003600_bib15","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/jth.15274","article-title":"Severe thrombophilia in a factor V-deficient patient homozygous for the Ala2086Asp mutation (FV Besancon)","volume":"19","author":"Castoldi","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"issue":"12","key":"2025011415312003600_bib16","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1111\/jth.14594","article-title":"The roles of factor Va and protein S in formation of the activated protein C\/protein S\/factor Va inactivation complex","volume":"17","author":"Gierula","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"issue":"15","key":"2025011415312003600_bib17","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1182\/blood-2013-10-530089","article-title":"Novel FV mutation (W1920R, FVNara) associated with serious deep vein thrombosis and more potent APC resistance relative to FVLeiden","volume":"123","author":"Nogami","year":"2014","journal-title":"Blood"},{"issue":"12","key":"2025011415312003600_bib18","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1182\/bloodadvances.2022008918","article-title":"Impaired factor V-related anticoagulant mechanisms and deep vein thrombosis associated with A2086D and W1920R mutations","volume":"7","author":"Shimonishi","year":"2023","journal-title":"Blood Adv"},{"issue":"5","key":"2025011415312003600_bib19","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/jth.15273","article-title":"Factor V mutation illuminates the dominant anticoagulant role and importance of an unidentified platelet modifier","volume":"19","author":"Ahnstrom","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"2025011415312003600_bib20","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V97.6.1549","article-title":"Characterization of a novel autosomal dominant bleeding disorder in a large kindred from east Texas","volume":"97","author":"Kuang","year":"2001","journal-title":"Blood"},{"issue":"9","key":"2025011415312003600_bib21","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1172\/JCI69091","article-title":"Coagulation factor V(A2440G) causes East Texas bleeding disorder via TFPIalpha","volume":"123","author":"Vincent","year":"2013","journal-title":"J\u00a0Clin Invest"},{"issue":"0 1","key":"2025011415312003600_bib22","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1111\/jth.12897","article-title":"New insights into the biology of tissue factor pathway inhibitor","volume":"13 Suppl 1","author":"Maroney","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"issue":"11","key":"2025011415312003600_bib23","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1182\/blood-2014-08-592733","article-title":"A\u00a0novel mutation in the F5 gene (factor V Amsterdam) associated with bleeding independent of factor V procoagulant function","volume":"125","author":"Cunha","year":"2015","journal-title":"Blood"},{"issue":"7","key":"2025011415312003600_bib24","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/jth.15314","article-title":"F5-Atlanta: a novel mutation in F5 associated with enhanced East Texas splicing and FV-short production","volume":"19","author":"Zimowski","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"2025011415312003600_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/rth2.12058","article-title":"Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and protein S","volume":"2","author":"Ellery","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"2025011415312003600_bib26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/rth2.12057","article-title":"Factor V-short and protein S as synergistic tissue factor pathway inhibitor (TFPIalpha) cofactors","volume":"2","author":"Dahlback","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"issue":"12","key":"2025011415312003600_bib27","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1016\/j.jtha.2023.09.003","article-title":"The TFPIalpha C-terminal tail is essential for TFPIalpha-FV-short-protein S complex formation and synergistic enhancement of TFPIalpha","volume":"21","author":"Gierula","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"2025011415312003600_bib28","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1160\/TH07-02-0150","article-title":"Coagulation factor V and thrombophilia: background and mechanisms","volume":"98","author":"Segers","year":"2007","journal-title":"Thromb Haemost"},{"issue":"6","key":"2025011415312003600_bib29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00001721-200009000-00003","article-title":"Method-dependent influence of certain polymorphisms in the factor V B-domain on the response to activated protein C","volume":"11","author":"Siegert","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"6","key":"2025011415312003600_bib30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0049-3848(00)00283-8","article-title":"Frequency of polymorphisms in the B-domain of factor V gene in APC-resistant patients","volume":"99","author":"Kostka","year":"2000","journal-title":"Thromb Res"},{"issue":"1","key":"2025011415312003600_bib31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1160\/TH09-06-0356","article-title":"Thrombin generation as an intermediate phenotype for venous thrombosis","volume":"103","author":"Segers","year":"2010","journal-title":"Thromb Haemost"},{"issue":"1","key":"2025011415312003600_bib32","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1038\/s41598-019-40172-x","article-title":"Minor allele of the factor V K858R variant protects from venous thrombosis only in non-carriers of factor V Leiden mutation","volume":"9","author":"Ibrahim-Kosta","year":"2019","journal-title":"Sci Rep"},{"key":"2025011415312003600_bib33","doi-asserted-by":"publisher","DOI":"10.1101\/2023.11.25.23299014","article-title":"Genetic determinants of blood gene expression and splicing and their contribution to molecular phenotypes and health outcomes","author":"Tokolyi","year":"27  2023","journal-title":"medRxiv"},{"key":"2025011415312003600_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-6215-15-363","article-title":"The INTERVAL trial to determine whether intervals between blood donations can be safely and acceptably decreased to optimise blood supply: study protocol for a randomised controlled trial","volume":"15","author":"Moore","year":"2014","journal-title":"Trials"},{"issue":"5","key":"2025011415312003600_bib35","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.cell.2016.10.042","article-title":"The allelic landscape of human blood cell trait variation and links to common complex disease","volume":"167","author":"Astle","year":"2016","journal-title":"Cell"},{"issue":"7955","key":"2025011415312003600_bib36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41586-023-05844-9","article-title":"An atlas of genetic scores to predict multi-omic traits","volume":"616","author":"Xu","year":"2023","journal-title":"Nature"},{"issue":"1","key":"2025011415312003600_bib37","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41467-023-37266-6","article-title":"Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer","volume":"14","author":"Cotto","year":"2023","journal-title":"Nat Commun"},{"issue":"2","key":"2025011415312003600_bib38","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1182\/bloodadvances.2021005382","article-title":"Laminin G1 residues of protein S mediate its TFPI cofactor function and are competitively regulated by C4BP","volume":"6","author":"Teraz-Orosz","year":"2022","journal-title":"Blood Adv"},{"issue":"157","key":"2025011415312003600_bib39","first-page":"1","article-title":"LDlinkR: an R package for rapidly calculating linkage disequilibrium statistics in diverse populations","volume":"11","author":"Myers","year":"2020","journal-title":"Front Genet"},{"issue":"21","key":"2025011415312003600_bib40","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1093\/bioinformatics\/btv402","article-title":"LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants","volume":"31","author":"Machiela","year":"2015","journal-title":"Bioinformatics"},{"issue":"7422","key":"2025011415312003600_bib41","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature11632","article-title":"An integrated map of genetic variation from 1,092 human genomes","volume":"491","author":"The 1000 Genomes Project Consortium","year":"2012","journal-title":"Nature"},{"issue":"25","key":"2025011415312003600_bib42","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1182\/blood-2012-05-432005","article-title":"Identification of functionally important residues in TFPI Kunitz domain 3 required for the enhancement of its activity by protein S","volume":"120","author":"Ahnstrom","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2025011415312003600_bib43","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1538-7836.2009.03712.x","article-title":"Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma","volume":"8","author":"Castoldi","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"2025011415312003600_bib44","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2217\/14622416.6.6.639","article-title":"UK Biobank: from concept to reality","volume":"6","author":"Ollier","year":"2005","journal-title":"Pharmacogenomics"},{"issue":"7","key":"2025011415312003600_bib45","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/s41588-021-00885-0","article-title":"Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank","volume":"53","author":"Szustakowski","year":"2021","journal-title":"Nat Genet"},{"issue":"24","key":"2025011415312003600_bib46","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood.2023020118","article-title":"The effects of pathogenic and likely pathogenic variants for inherited hemostasis disorders in 140 214 UK Biobank participants","volume":"142","author":"Stefanucci","year":"2023","journal-title":"Blood"},{"issue":"1","key":"2025011415312003600_bib47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1538-7836.2008.03222.x","article-title":"Biochemical characterization of plasma-derived tissue factor pathway inhibitor: post-translational modification of free, full-length form with particular reference to the sugar chain","volume":"7","author":"Mori","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"issue":"100234","key":"2025011415312003600_bib48","first-page":"1","article-title":"Regulation of factor V and factor V-short by TFPIalpha: relationship between B-domain proteolysis and binding","volume":"296","author":"Petrillo","year":"2021","journal-title":"J Biol Chem"},{"issue":"12","key":"2025011415312003600_bib49","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/pro.2552","article-title":"Single nucleotide variations: biological impact and theoretical interpretation","volume":"23","author":"Katsonis","year":"2014","journal-title":"Protein Sci"},{"issue":"7708","key":"2025011415312003600_bib50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","article-title":"Genomic atlas of the human plasma proteome","volume":"558","author":"Sun","year":"2018","journal-title":"Nature"},{"issue":"1","key":"2025011415312003600_bib51","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1538-7836.2007.02824.x","article-title":"Coagulation factors and the protein C system as determinants of thrombin generation in a normal population","volume":"6","author":"Dielis","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"2025011415312003600_bib52","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/jth.15690","article-title":"A\u00a0hydrophobic patch (PLVIVG; 1481-1486) in the B-domain of factor V-short is crucial for its synergistic TFPIalpha-cofactor activity with protein S and for the formation of the FXa-inhibitory complex comprising FV-short, TFPIalpha, and protein S","volume":"20","author":"Dahlback","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"2025011415312003600_bib53","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1182\/bloodadvances.2020003464","article-title":"Elevated levels of tissue factor pathway inhibitor in patients with mild to moderate bleeding tendency","volume":"5","author":"Mehic","year":"2021","journal-title":"Blood Adv"},{"issue":"12","key":"2025011415312003600_bib54","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/35103535","article-title":"Accessing genetic variation: genotyping single nucleotide polymorphisms","volume":"2","author":"Syvanen","year":"2001","journal-title":"Nat Rev Genet"},{"issue":"5","key":"2025011415312003600_bib55","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/jama.297.5.489","article-title":"Association of genetic variations with nonfatal venous thrombosis in postmenopausal women","volume":"297","author":"Smith","year":"2007","journal-title":"JAMA"},{"issue":"6","key":"2025011415312003600_bib56","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1055\/s-0037-1613399","article-title":"A\u00a0FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers","volume":"89","author":"Mingozzi","year":"2003","journal-title":"Thromb Haemost"},{"issue":"9","key":"2025011415312003600_bib57","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2008-06-162453","article-title":"Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency","volume":"112","author":"Duckers","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2025011415312003600_bib58","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/jth.15547","article-title":"The preAR2 region (1458-1492) in factor V-Short is crucial for the synergistic TFPIalpha-cofactor activity with protein S and the assembly of a trimolecular factor Xa-inhibitory complex comprising FV-Short, protein S, and TFPIalpha","volume":"20","author":"Dahlback","year":"2022","journal-title":"J\u00a0Thromb Haemost"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/1\/132\/2349991\/blooda_adv-2024-014020-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/1\/132\/2349991\/blooda_adv-2024-014020-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T15:59:45Z","timestamp":1736870385000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/1\/132\/518047\/The-common-VTE-protective-G-haplotype-of-F5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024014020","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,31]]}}}